Skip to Content
Merck
All Photos(1)

Documents

T-011

Supelco

(−)-Δ9-THC-D3 solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C21H27O2D3
CAS Number:
81586-39-2
Molecular Weight:
317.48
EC Number:
200-659-6
UNSPSC Code:
41116107
NACRES:
NA.24

grade

certified reference material

form

liquid

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

drug control

Narcotic Licence Schedule D (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)

concentration

1.0 mg/mL in methanol

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

cannabis testing
cannabis testing

format

single component solution

storage temp.

−20°C

InChI

1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/i1D3

InChI key

CYQFCXCEBYINGO-FIBGUPNXSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

It is an internal standard of Δ9-THC, the main active constituent and the primary psychoactive cannabinoid of cannabis.

Application

This Certified Spiking Solution® is suitable as an internal standard for quantitation of Δ9-THC levels in urine or other matrices by LC/MS or GC/MS for pharmaceutical research, clinical toxicology, or forensic testing applications.

The Certified Reference Material (CRM) in solution can also be used as follows:

  • Development of an automated sample preparation method based on solid phase extraction (SPE) to determine ∆9-tetrahydrocannabinol (THC) and its three primary metabolites in a variety of matrices, such as serum, saliva, and urine using liquid chromatography-mass spectrometry (LC-MS)
  • Comparative analysis of two methods based on ultra high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method and solid phase microextraction-gas chromatography-mass spectrometry (SPME-GC/MS) to measure cannabinoids in oral fluid samples of small volumes
  • As an internal standard in high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) based quantitative assay of 11 cannabinoids and their metabolites in human urine and plasma samples

Features and Benefits

  • Fully characterized under ISO/IEC 17025 and ISO 17034 accreditation
  • Accompanied with a comprehensive Certificate of Analysis (CoA) with data on stability, homogeneity, accuracy of concentration, uncertainty, and traceability
  • Rigorously tested through real-time stability studies to ensure accuracy and shelf life
  • Gravimetrically prepared using qualified precision balances to ensure minimal uncertainty
  • Flame sealed under argon into ampoules for long-term shelf life
  • Offered in a convenient, DEA-exempt format to improve laboratory efficiency

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

related product

Product No.
Description
Pricing

C-115

Cannabinol-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-026

(±)-11-Hydroxy-Δ9-THC solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-027

(±)-11-Hydroxy-Δ9-THC solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-041

(±)-11-Hydroxy-Δ9-THC-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-003

(−)-Δ9-THC-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-004

(±)-11-nor-9-Carboxy-Δ9-THC-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-005

(−)-trans-Δ9-THC solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-006

(±)-11-nor-9-Carboxy-Δ9-THC solution, 100 μg/mL in methanol, ampule of 1 mL, Cerilliant®

T-007

(±)-11-nor-9-Carboxy-Δ9-THC-D9 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-008

(±)-11-nor-9-Carboxy-Δ9-THC-D3 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-018

(−)-11-nor-9-Carboxy-Δ9-THC solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-019

(−)-11-nor-9-Carboxy-Δ9-THC solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-038

(+)-11-Nor-Δ9-THC-9-carboxylic acid glucuronide solution, 100 μg/mL in methanol, ampule of 1 mL, Cerilliant®

T-047

(±)-Δ9-THC solution, 100 μg/mL in heptane, ampule of 1 mL, Cerilliant®

T-080

(±)-cis-11-Nor-9-carboxy-Δ9-THC-D3 glucuronide solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

C-150

Cannabichromenic Acid (CBCA) solution, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-153

Cannabinolic Acid (CBNA) solution, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

T-111

Tetrahydrocannabivarinic acid (THCVA) solution, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-171

Cannabicyclolic Acid (CBLA) solution, 0.5 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-217

Hemp Compliance Mix solution, certified reference material, ampule of 1 mL, Cerilliant®

C-219

Cannabinoid Mixture (Neutrals) - 8 Component solution, 500 μg/mL in methanol (each analyte), certified reference material, ampule of 1 mL, Cerilliant®

T-151

THC-O-Acetate solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-220

Cannabinoid Mixture - 3 Component solution, 1 mg/mL in methanol ((each analyte)), certified reference material, ampule of 1 mL, Cerilliant®

C-218

Cannabinoid Mixture (Acids) - 6 Component solution, 500 μg/mL (1% DIPEA and 0.05% Ascorbic acid in Acetonitrile,each analyte), certified reference material, ampule of 1 mL, Cerilliant®

T-112

11-Nor-9-carboxy-delta9-THCV solution, 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-244

Cannabichromenic Acid (CBCA) solution, 1 mg/mL (1% DIPEA and 0.05% Ascorbic acid in Acetonitrile), certified reference material, ampule of 1 mL, Cerilliant®

C-264

(±)-Cannabicyclolic Acid (CBLA) solution, 0.5 mg/mL (0.1% DIPEA, 0.05 Ascorbic Acid in Acetonitrile), certified reference material, ampule of 1 mL, Cerilliant®

H-166

11-Nor-9beta-hydroxyhexahydrocannabinol (11-Nor-9beta-HHC) solution, 1 mg/mL (Acetonitrile (Degas)), certified reference material, ampule of 1 mL, Cerilliant®

T-158

(-)-11-nor-9-Carboxy-Delta8-THC-D3 solution, 100 μg/mL (Degassed Methanol), certified reference material, ampule of 1 mL, Cerilliant®

T-182

THC-O-Acetate solution, 1 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

T-114

(-)-delta9-THC-O-beta-D-glucuronide sodium salt solution, 100 μg/mL (Degassed Methanol, (as free carboxylate)), certified reference material, ampule of 1 mL, Cerilliant®

H-165

Hexahydrocannabinol (HHC) solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Target Organs

Eyes

Storage Class Code

3 - Flammable liquids

WGK

WGK 1

Flash Point(F)

49.5 °F - closed cup

Flash Point(C)

9.7 °C - closed cup

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Dirk W Lachenmeier et al.
F1000Research, 8, 1394-1394 (2019-08-08)
Cannabidiol (CBD)-containing products are widely marketed as over the counter products, mostly as food supplements. Adverse effects reported in anecdotal consumer reports or during clinical studies were first assumed to be due to hydrolytic conversion of CBD to psychotropic Δ
Michal P Dybowski et al.
Forensic toxicology, 36(2), 415-423 (2018-07-03)
Analysis of drugs and their metabolites in biofluids usually demands the application of sample preparation methods that allow for full isolation of analyzed substances from the matrix. The purpose of this study was to develop a method using the QuEChERS
Florentina Villanueva et al.
International journal of hygiene and environmental health, 218(6), 522-534 (2015-05-31)
Twenty nine organic air pollutants including carbonyl compounds, alkanes, aromatic hydrocarbons and terpenes were measured in the indoor environment of different houses together with the corresponding outdoor measurements in Puertollano, the most industrialized city in central Iberian Peninsula. VOCs were

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service